, BIBLIOGRAPHIQUES

S. Samet, E. Nunes, and D. Hasin, Acta Neuropsychiatrica, vol.49, issue.01, pp.9-18, 2004.
DOI : 10.1001/archpsyc.1984.01790210041006

, Cottencin O, Severe depression and addictions Encéphale, vol.35, issue.7, pp.264-268, 2009.

R. Habibisaravi, S. Navaeinia, S. Farnia, and M. , Zarghami Alcohol, cannabinoids, and opioids abuse and dependence among psychiatric inpatients Iran J, Psychiatry Behav. Sci, vol.9, issue.1, p.229, 2015.
DOI : 10.5812/ijpbs.229

URL : http://cdn.neoscriber.org/cdn/serve/88/87/888798bfff6b4b5dc06ed53544fb59ae5b6ae6f1/ijpbs-09-229.pdf

S. Ross and E. , Co-Occurring Psychotic and Addictive Disorders, Clinical Neuropharmacology, vol.35, issue.5, pp.235-243, 2012.
DOI : 10.1097/WNF.0b013e318261e193

D. Regier, M. Farmer, D. Rae, B. Locke, S. Keith et al., Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study, JAMA: The Journal of the American Medical Association, vol.264, issue.19, pp.2511-2519, 1990.
DOI : 10.1001/jama.264.19.2511

R. Kessler, K. Mcgonagle, S. Zhao, C. Nelson, M. Hughes et al., Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States, Archives of General Psychiatry, vol.51, issue.1, pp.8-19, 1994.
DOI : 10.1001/archpsyc.1994.03950010008002

W. Compton, Y. Thomas, F. Stinson, and B. Grant, Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Drug Abuse and Dependence in the United States, Archives of General Psychiatry, vol.64, issue.5, pp.566-76, 2007.
DOI : 10.1001/archpsyc.64.5.566

I. Gasquet, L. Negre-pages, A. Fourrier, G. Nachbaur, A. El-hasnaoui et al., Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD, 2005.

, MarApr, vol.31, issue.2, pp.195-206

, Results from the 2011 National Survey on Drug Use and Health : Mental Health Findings. NSDUH Series H-45, SAMHSA, 2012.

, Substance Abuse and Mental Health Services Administration, Results from the 2012 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-47, Substance Abuse and Mental Health Services Administration, pp.13-4805, 2013.

E. K. Cridland and F. Dean, A Comparison of Treatment Outcomes for Individuals with Substance Use Disorder Alone and Individuals with Probable Dual Diagnosis, International Journal of Mental Health and Addiction, vol.33, issue.3, pp.670-683
DOI : 10.1023/A:1025085310814

L. Hermle and R. Szlak-rubin, Substance use associated disorders, Der Nervenarzt, vol.257, issue.3, pp.315-340, 2013.
DOI : 10.1007/s00406-006-0707-x

D. Ziedonis and D. Smelson, Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations, Journal of Psychiatric Practice, vol.11, issue.5, pp.315-354, 2005.
DOI : 10.1097/00131746-200509000-00005

G. Carra and S. Johnson, The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC), European Archives of Psychiatry and Clinical Neuroscience, vol.261, issue.suppl 1, pp.607-616, 2012.
DOI : 10.1007/s00406-011-0188-4

, Center for disease Control and Prevention (CDC)Cigarette smoking among adults-united States, MMWR Morb Mortal Wkly Rep, vol.54, pp.1121-1124, 2004.

S. Brown, H. Inskip, and B. Barraclough, Conclusions, British Journal of Psychiatry, vol.177, issue.03, pp.212-219, 2000.
DOI : 10.1192/bjp.177.3.212

A. Green and M. Tohen, First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol, Schizophrenia Research, vol.66, issue.2-3, pp.125-160, 2004.
DOI : 10.1016/j.schres.2003.08.001

M. Hambrecht and H. Häfner, Substance abuse and the onset of schizophrenia, Biological Psychiatry, vol.40, issue.11, pp.1155-63, 1996.
DOI : 10.1016/S0006-3223(95)00609-5

G. Hunt, G. Malhi, M. Cleary, H. Lai, and T. Sitharthan, Prevalence of comorbid bipolar and substance use disorders in clinical settings Systematic review and metaanalysis, J Affect Disord. Review, vol.2016206, pp.331-349, 1990.

F. Cassidy, E. Ahearn, and B. Carroll, Substance abuse in bipolar disorder, Bipolar Disorders, vol.36, issue.3, pp.181-189, 2001.
DOI : 10.1176/ajp.149.4.554

R. Kessler, A. Sonnega, E. Bromet, M. Hughes, and C. Nelson, Posttraumatic Stress Disorder in the National Comorbidity Survey, Archives of General Psychiatry, vol.52, issue.12, pp.1048-1060, 1995.
DOI : 10.1001/archpsyc.1995.03950240066012

P. Najt, P. Fusar-poli, and P. Brambilla, Co-occurring mental and substance abuse disorders: A review on the potential predictors and clinical outcomes, Psychiatry Research, vol.186, issue.2-3, 2010.
DOI : 10.1016/j.psychres.2010.07.042

I. Petrakis and T. Simpson, Posttraumatic Stress Disorder and Alcohol Use Disorder: A??Critical Review of Pharmacologic Treatments, Alcoholism: Clinical and Experimental Research, vol.123, issue.2, p.2017
DOI : 10.1016/j.brainresbull.2016.05.005

. Feb, Review, vol.41, issue.2, pp.226-237, 2017.

K. Lasser and B. J. , Smoking and Mental Illness, JAMA, vol.284, issue.20, pp.2606-2616, 2000.
DOI : 10.1001/jama.284.20.2606

B. Grant and D. Hasin, Nicotine Dependence and Psychiatric Disorders in the United States, Archives of General Psychiatry, vol.61, issue.11, pp.1107-1122, 2004.
DOI : 10.1001/archpsyc.61.11.1107

J. Alonso and J. Lépine, Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD), J Clin Psychiatry, vol.68, issue.2, pp.3-9, 2007.

D. Hasin, F. Stinson, E. Ogburn, and B. Grant, Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States, Archives of General Psychiatry, vol.64, issue.7, pp.830-872, 2007.
DOI : 10.1001/archpsyc.64.7.830

M. Farrell and S. Howes, Nicotine, alcohol and drug dependence, and psychiatric comorbidity--results of a national household survey, International Review of Psychiatry, vol.15, issue.1-2, pp.432-439, 2001.
DOI : 10.1080/0954026021000045949

B. Green and R. Young, Conclusions, British Journal of Psychiatry, vol.187, issue.04, pp.306-313, 2005.
DOI : 10.1192/bjp.187.4.306

J. Koskinen and J. Löhönen, Rate of cannabis usedisorders in clinical samples of patients with schizophrenia: a meta-analysis Schizophr Bull, pp.1115-1130, 2010.

S. Fs and W. Ruan, Cannabis use disorders in the USA: prevalence, correlates and co-morbidity, Psychol Med, vol.36, pp.1447-1460, 2006.

M. Balas and C. Psychiatriques, Prévalence chez les toxicomanes fréquentant un centre de soins spécialisés, Le Flyer HS N°3, vol.2, 2004.

A. Dervaux and M. Krebs, Alcohol use disorders in patients with cannabis dependence seeking treatment, European Neuropsychopharmacology, vol.27, issue.1, p.40, 2013.
DOI : 10.1016/S0924-977X(17)31870-9

A. Dervaux and M. Krebs, Is cannabis responsible for early onset psychotic illnesses?, Neuropsychiatry, vol.1, issue.3, pp.203-207, 2011.
DOI : 10.2217/npy.11.31

I. Maremmani and G. Perugi, Toward a unitary perspective on the bipolar spectrum and substance abuse: Opiate addiction as a paradigm, Journal of Affective Disorders, vol.93, issue.1-3, pp.1-12, 2006.
DOI : 10.1016/j.jad.2006.02.022

A. Maremmani and . Dell-'osso, Dual Diagnosis and Chronology of Illness in Treatment-Seeking Italian Patients Dependent on Heroin, Journal of Addictive Diseases, vol.73, issue.2, pp.123-135, 2011.
DOI : 10.1016/j.jad.2009.06.012

B. Schneider and T. Wetterling, Axis I disorders and personality disorders as risk factors for suicide, European archives of psychiatry and clinical neuroscience, pp.17-27, 2006.

Y. Yoon, Effect of comorbid alcohol and drug use disorders on premature death among unipolar and bipolar disorder decedents in the United States, 1999 to 2006, Comprehensive Psychiatry, vol.52, issue.5, pp.453-464, 1999.
DOI : 10.1016/j.comppsych.2010.10.005

R. Callaghan and S. Veldhuizen, Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression, Journal of Psychiatric Research, vol.48, issue.1, 2014.
DOI : 10.1016/j.jpsychires.2013.09.014

J. Schein, Cigarette smoking and clinically significant drug interactions, The Annals of Pharmacotherapy, pp.1139-1148, 1995.

S. Kellerman and D. Hanson, Prevalence of Chronic Hepatitis B and Incidence of Acute Hepatitis B Infection in Human Immunodeficiency Virus???Infected Subjects, The Journal of Infectious Diseases, vol.188, issue.4, 2003.
DOI : 10.1086/377135

, Aug Epub, vol.15188, issue.4, pp.571-578, 2003.

A. J. Shabia and M. Charvat, Point of entry and functional impairment as predictors of treatment amount and cost for patients with mental illness and substance abuse disorders in Santa Barbara County Mental Health Services, Psychological Services, vol.7, issue.1, pp.44-56

F. Jacobi and H. Wittchen, Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS), Psychological Medicine, vol.34, issue.4, pp.597-611
DOI : 10.1017/S0033291703001399

K. E. Kerfoot and P. I. , Dual Diagnosis in an Aging Population: Prevalence of Psychiatric Disorders, Comorbid Substance Abuse, and Mental Health Service Utilization in the Department of Veterans Affairs, Journal of Dual Diagnosis, vol.61, issue.6, pp.4-13, 2011.
DOI : 10.1001/archpsyc.1988.01800350011002

A. Minassian and G. M. Vilke, Frequent Emergency Department Visits are More Prevalent in Psychiatric, Alcohol Abuse, and Dual Diagnosis Conditions than in Chronic Viral Illnesses Such as Hepatitis and Human Immunodeficiency Virus, The Journal of Emergency Medicine, vol.45, issue.4, pp.520-525, 2013.
DOI : 10.1016/j.jemermed.2013.05.007

N. Virgo and G. Bennett, The prevalence and characteristics of co-occuring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addictions Services in eastern Dorset, Journal of Mental Health, vol.10, issue.2, pp.175-188, 2001.

E. Khantzian, The Self-Medication Hypothesis of Addictive Disorders: Focus on Heroin and Cocaine Dependence, Am J Psychiatry, vol.142, issue.11, pp.1259-64, 1985.
DOI : 10.1007/978-1-4613-1837-8_7

M. Casas, Trastornos Psiquicos en las Toxicomanias, 1992.

P. Murthy and P. Chand, Treatment of dual diagnosis disorders, Current Opinion in Psychiatry, vol.25, issue.3, pp.194-200, 2012.
DOI : 10.1097/YCO.0b013e328351a3e0

M. Casas, La Patologia Dual como una forma de presentacion de la comorbilidad entre Trastornos Psiquicos y las Toxicomanias,I Congreso CITRAN, Trastornos Psiquicos en las Toxicomanias, 1986.

R. E. Meyer, How to understand the Relationship between psychopathology and addictive disorders: Another example of the chicken and the egg, Psychophatology and Addictive Disorders, pp.3-16, 1986.

, 2014) Addictions et comorbidités

K. Mueser, R. Drake, and M. Wallach, Dual diagnosis, Addictive Behaviors, vol.23, issue.6, pp.717-751, 1998.
DOI : 10.1016/S0306-4603(98)00073-2

S. Potvin, E. Stip, and J. Roy, Schizophrénie et toxicomanie : une relecture du concept d'automédication, Encéphale, vol.XXXIX, pp.193-203, 2003.

L. Dixon, Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes, Schizophrenia Research, vol.35, pp.93-100, 1999.
DOI : 10.1016/S0920-9964(98)00161-3

M. Birchwood, R. Mason, and F. Macmillan, Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis, Psychological Medicine, vol.138, issue.02, pp.387-395, 1993.
DOI : 10.1176/ajp.138.6.797

S. B. Bartels and D. R. , Depressive symptoms in schizophrenia: Comprehensive differential diagnosis, Comprehensive Psychiatry, vol.29, issue.5, pp.467-483, 1988.
DOI : 10.1016/0010-440X(88)90062-4

J. Addington and V. Duchak, Reasons for substance use in schizophrenia, Acta Psychiatrica Scandinavica, vol.16, issue.5, pp.329-333, 1997.
DOI : 10.1093/schbul/15.3.465

R. P. Liberman, M. K. , and W. C. , Training Skills in the Psychiatrically Disabled: Learning Coping and Competence, Schizophrenia Bulletin, vol.12, issue.4, pp.631-647, 1986.
DOI : 10.1093/schbul/12.4.631

D. R. Wallach and M. , A, Moderate drinking among people with severe mental illness Hospital and Community Psychiatry, pp.780-782, 1993.

C. Henquet and L. Krabbendam, Cannabis use and expression of mania in the general population, Journal of Affective Disorders, vol.95, issue.1-3, pp.103-110, 2006.
DOI : 10.1016/j.jad.2006.05.002

S. Andréasson and P. Allebeck, CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts, The Lancet, vol.330, issue.8574, pp.1483-1489, 1987.
DOI : 10.1016/S0140-6736(87)92620-1

S. Zammit and P. Allebeck, Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study, BMJ, vol.325, issue.7374, p.1199, 2002.
DOI : 10.1136/bmj.325.7374.1199

J. Ades and M. Lejoyeux, Alcoolisme et psychiatrie, données actuelles et perspectives, 2003.

M. Mameli and C. Luscher, Synaptic plasticity and addiction: Learning mechanisms gone awry, Neuro-pharmacology, pp.1052-1059, 2011.
DOI : 10.1016/j.neuropharm.2011.01.036

D. Lovinger and R. M. , Synaptic Effects Induced by Alcohol, Curr Top Behav Neurosci, vol.13, pp.31-86, 2013.
DOI : 10.1007/978-3-642-28720-6_143

URL : http://europepmc.org/articles/pmc4791588?pdf=render

K. Merikangas and N. Risch, Genomic Priorities and Public Health, Genomic priorities and public health, pp.599-601, 2003.
DOI : 10.1126/science.1091468

P. Gorwood and Y. Lestrat, Comorbidit?? addictive des troubles bipolaires, L'Enc??phale, vol.34, pp.138-180, 2008.
DOI : 10.1016/S0013-7006(08)80624-0

J. Zubin and B. Spring, Vulnerability: A new view of schizophrenia., Journal of Abnormal Psychology, vol.86, issue.2, pp.103-123, 1977.
DOI : 10.1037/0021-843X.86.2.103

G. E. and D. L. , A controlled family study of chronic psychoses: Schizophrenia and schizoaffective disorder, Archives of General Psychiatry, vol.45, pp.328-336, 1988.

R. C. Kessler, Lifetime Co-occurrence of DSM-III-R Alcohol Abuse and Dependence With Other Psychiatric Disorders in the National Comorbidity Survey, Archives of General Psychiatry, vol.54, issue.4, pp.313-321, 1997.
DOI : 10.1001/archpsyc.1997.01830160031005

A. I. Alterman and C. J. , The Antisocial Personality Disorder Diagnosis in Substance Abusers, The Journal of Nervous and Mental Disease, vol.179, issue.7, pp.401-409, 1991.
DOI : 10.1097/00005053-199107000-00003

C. L. Caton, Mental health service use among homeless and never-homeless men with schizophrenia, Psychiatric Services, vol.46, pp.1139-1143, 1995.

C. L. Caton and P. E. Shrout, Risk factors for homelessness among women with schizophrenia., American Journal of Public Health, vol.85, issue.8_Pt_1, pp.265-270, 1994.
DOI : 10.2105/AJPH.85.8_Pt_1.1153

D. R. Brunette and M. F. , Complications of severe mental illness related to alcohol and drug use disorders, M Galanter The consequences of alcohol, Recent developments in alcoholism, pp.285-299, 1998.

I. and I. , Expertise collective, Conduite addictive chez les jeunes, 2014.

H. Verdoux, C. Gindre, and F. Sorbara, Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study, Psychological Medicine, vol.33, issue.01, pp.23-32, 2003.
DOI : 10.1017/S0033291702006384

Y. Morvan and J. Rouvier, Student's use of illicit drugs : a survey in a preventive health service, Encephale, issue.6, pp.35-202, 2009.

D. Souza, D. Sewell, and R. , Cannabis and psychosis/schizophrenia : human studies, Eur Arch Psychiatry Clin Neurosci, vol.259, pp.413-431, 2009.

X. Laqueille and A. Dervaux, Cannabis et troubles schizophréniques Paris : Flammarion, pp.63-70, 2009.

N. Solowij and M. P. , Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia ?, J Psychiatry Neurosci, vol.32, issue.1, pp.30-52, 2007.

M. Smith and J. Thirthalli, Prevalence of psychotic symptoms in substance users: a comparison across substances, Comprehensive Psychiatry, vol.50, issue.3, pp.245-250, 2009.
DOI : 10.1016/j.comppsych.2008.07.009

J. Niemi-pynttäri and R. Sund, Substance-Induced Psychoses Converting Into Schizophrenia, The Journal of Clinical Psychiatry, vol.74, issue.01, pp.94-99, 2013.
DOI : 10.4088/JCP.12m07822

S. Monterrubio, N. Solowij, and B. Meyer, Fatty acid relationships in former cannabis users with schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.30, issue.2, pp.280-285, 2006.
DOI : 10.1016/j.pnpbp.2005.08.013

A. White and H. Swartzwelder, Hippocampal Function during Adolescence: A Unique Target of Ethanol Effects, Annals of the New York Academy of Sciences, vol.24, issue.1, pp.206-226, 2004.
DOI : 10.1111/j.1530-0277.2000.tb01973.x

J. Rey, A. Martin, and P. Krabman, Is the Party Over? Cannabis and Juvenile Psychiatric Disorder: The Past 10 Years, Journal of the American Academy of Child & Adolescent Psychiatry, vol.43, issue.10, pp.1194-205, 2004.
DOI : 10.1097/01.chi.0000135623.12843.60

L. Jacobsen, W. Mencl, and M. Westerveld, Impact of Cannabis Use on Brain Function in Adolescents, Annals of the New York Academy of Sciences, vol.13, issue.1, pp.384-90, 2004.
DOI : 10.1006/nimg.2000.0726

H. Pope, A. Gruber, and J. Hudson, Early-onset cannabis use and cognitive deficits: what is the nature of the association?, Drug and Alcohol Dependence, vol.69, issue.3, pp.303-313, 2003.
DOI : 10.1016/S0376-8716(02)00334-4

F. Wagner and J. Anthony, From First Drug Use to Drug Dependence Developmental Periods of Risk for Dependence upon Marijuana, Cocaine, and Alcohol, Neuropsychopharmacology, vol.26, issue.4, pp.479-88, 2002.
DOI : 10.1016/S0893-133X(01)00367-0

J. M. Boden and D. M. Fergusson, Alcohol and depression Addiction, vol.106, issue.5, pp.906-920, 2011.

L. Radloff, The CES-D Scale, Applied Psychological Measurement, vol.23, issue.3, pp.385-401, 1997.
DOI : 10.1001/archpsyc.1965.01720310065008

B. D. Berger and A. V. , Gender differences in using alcohol to cope with depression, Addictive Behaviors, vol.16, issue.5, pp.315-342, 1991.
DOI : 10.1016/0306-4603(91)90024-C

G. B. Hasin and D. , The relationship between DSM-IV alcohol use disorders and DSM-IV major depression : examination of the primary-secondary distinction in a general population sample, Journal of affective disorders, vol.38, pp.2-3, 1996.

T. K. Melartin and R. H. , Severity and Comorbidity Predict Episode Duration and Recurrence of DSM-IV Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.65, issue.6, pp.810-819, 2004.
DOI : 10.4088/JCP.v65n0612

W. B. Jaffee and M. Griffin, Depression Precipitated by Alcohol Use in Patients With Co-Occurring Bipolar and Substance Use Disorders, The Journal of Clinical Psychiatry, vol.70, issue.2, pp.171-176, 2009.
DOI : 10.4088/JCP.08m04011

I. M. Salloum and C. J. , Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation, Bipolar Disorders, vol.141, issue.264, pp.418-421, 2002.
DOI : 10.1176/ajp.141.6.764

B. J. Cuffel and P. Et-chase, Remission and relapse of substance use disorders in schizophrenia . Results from a one-year prospective study, The Journal of nervous and mental disease, pp.342-348, 1994.

Y. Chang and C. S. , Neuropsychological functions in bipolar disorder I and II with and without comorbid alcohol dependence, Progress in neuropsychopharmacology and biological psychiatry, pp.211-216, 2012.
DOI : 10.1016/j.pnpbp.2012.01.015

S. Mohamed and M. Bondi, Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia, International Journal of Geriatric Psychiatry, vol.44, issue.8, pp.711-718, 2006.
DOI : 10.1176/ajp.136.12.1611-c

M. A. Schuckit and T. J. , Comparison of induced and independent major depressive disorders in 2945 alcoholics, Am J Psychiatry, vol.154, pp.948-57, 1997.

C. J. Maisto and S. , A, Major depression associated with earlier alcohol relapse in treated teens with AUD, Addict Behav, vol.29, pp.1035-1043, 2004.

K. R. Conner and D. P. , Predisposing and Precipitating Factors for Suicide Among Alcoholics: Empirical Review and Conceptual Integration, Alcoholism: Clinical and Experimental Research, vol.8, pp.6-17, 2004.
DOI : 10.1017/S0954579400007458

R. E. Tarter and A. Sugerman, Craving for Alcohol: Role of Drinking Pattern, Psychosocial History, Cognitive Style, Motor Control and Personality Variables, Adv Exp Med Biol, vol.85, pp.569-87, 1977.
DOI : 10.1007/978-1-4615-9038-5_36

J. F. Sanchez-pena and P. Alvarez-cotoli, Psychiatric disorders associated with alcoholism : 2 years follow-up of treatment, Actas Esp Psiquiatr, vol.40, issue.3, pp.129-164, 2012.

O. Mantere and K. Suominen, Concomitants of Family Histories of Mood Disorders and Alcoholism in a Clinical Cohort of Patients With Bipolar I and II Disorder, The Journal of Nervous and Mental Disease, vol.200, issue.5, pp.338-94, 2012.
DOI : 10.1097/NMD.0b013e3182531f2e

G. J. Lydall and N. J. Bass, Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder, Psychiatric Genetics, vol.21, issue.6, pp.294-306, 2011.
DOI : 10.1097/YPG.0b013e32834915c2

A. J. Heinz and A. Beck, Cognitive and neurobiological mechanisms of alcoholrelated agression, Nature reviews, Neuroscience, vol.12, issue.7, pp.400-413, 2011.

M. Torrens and F. Fonseca, Efficacy of antidepressants in substance use disorders with and without comorbid depression, Drug and Alcohol Dependence, vol.78, issue.1, pp.1-22, 2005.
DOI : 10.1016/j.drugalcdep.2004.09.004

G. P. Jordaan and R. Emsley, Alcohol-induced psychotic disorder: a review, Metabolic Brain Disease, vol.126, issue.1, 2013.
DOI : 10.1097/00005053-195805000-00006

N. Dunn and C. Et-cook, Psychiatric aspects of alcohol misuse, Hospital medi-cine, pp.169-172, 1998.
DOI : 10.12968/hosp.1999.60.3.1060

, Alcool et troubles mentaux, 2013.

K. S. Kendler and E. E. Walters, The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder , panic disorder, bulimia, major depression, and alcoholism, Archives of general psychiatry, pp.374-383, 1995.

P. J. Conrod, O. Leary-barrett, and M. , Effectiveness of a Selective, Personality-Targeted Prevention Program for Adolescent Alcohol Use and Misuse, JAMA Psychiatry, vol.70, issue.3, pp.334-342, 2013.
DOI : 10.1001/jamapsychiatry.2013.651

L. Lalanne and P. E. Lutz, Medications between psychiatric and addictive disorders, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.65, pp.215-238, 2015.
DOI : 10.1016/j.pnpbp.2015.10.009

URL : https://hal.archives-ouvertes.fr/hal-01489014

T. Kelly and D. Daley, Treatment of substance abusing patients with comorbid psychiatric disorders Addict Behav, pp.11-24, 2011.

Q. Tiet and B. Mausbach, Treatments for patients with dual diagnosis: a review, Alcohol Clin Exp Res, vol.31, issue.4, pp.513-549, 2007.
DOI : 10.1037/e698572007-001

N. Iovieno and E. Tedeschini, Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders, The Journal of Clinical Psychiatry, vol.72, issue.08, pp.1144-51, 2011.
DOI : 10.4088/JCP.10m06217

E. Nunes and F. Levin, Treatment of Depression in Patients With Alcohol or Other Drug Dependence, JAMA, vol.291, issue.15, pp.1887-1896, 2004.
DOI : 10.1001/jama.291.15.1887

H. Pettinati and D. Oslin, A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence, American Journal of Psychiatry, vol.167, issue.6, pp.668-75, 2010.
DOI : 10.1176/appi.ajp.2009.08060852

J. Cornelius and S. I. , Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial Archives of General Psychiatry, pp.700-705, 1997.
DOI : 10.1001/archpsyc.1997.01830200024004

D. H. Moak and A. R. , Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial, Journal of Clinical Psychopharmacology, vol.23, issue.6, pp.553-562, 2003.
DOI : 10.1097/01.jcp.0000095346.32154.41

H. Kranzler and J. Burleson, Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive-Behavioral Therapy in Type B Alcoholics, Alcoholism: Clinical and Experimental Research, vol.21, issue.Suppl., pp.153-194, 1996.
DOI : 10.3109/00952999509002701

J. Liappas and T. Paparrigopoulos, Mirtazapine Improves Alcohol Detoxification, Journal of Psychopharmacology, vol.18, issue.1, pp.88-93, 2004.
DOI : 10.1111/j.1530-0277.1991.tb00525.x

J. Liappas, T. Paparrigopoulos, and E. Tzavellas, Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification Prog

, Biol. Psychiatry, vol.29, issue.1, pp.55-60, 2005.

S. J. Yoon and P. C. , Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.30, issue.7, pp.1196-120116624467, 2006.
DOI : 10.1016/j.pnpbp.2006.02.018

S. Sonne and K. Brady, Substance abuse and bipolar comorbidity Psychiatric Clinics of North America, pp.609-627, 1999.
DOI : 10.1016/s0193-953x(05)70098-8

A. Swann, Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania, American Journal of Psychiatry, vol.156, issue.8, pp.1264-1266, 1999.

S. B. Quello, B. K. Sonne, and S. C. , Mood disorders and substance use disorder: A complex comorbidity Science & Practice Perspectives, pp.13-21, 2005.
DOI : 10.1151/spp053113

URL : http://europepmc.org/articles/pmc2851027?pdf=render

M. Albanese, R. Clodfelter, . Jr, and E. Khantzian, Divalproex Sodium in Substance Abusers With Mood Disorder, The Journal of Clinical Psychiatry, vol.61, issue.12, pp.916-921, 2000.
DOI : 10.4088/JCP.v61n1205

K. Brady, Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study, Journal of Clinical Psychiatry, vol.56, issue.3, pp.118-121, 1995.

M. Hertzman, Divalproex sodium to treat concomitant substance abuse and mood disorders, Journal of Substance Abuse Treatment, vol.18, issue.4, pp.371-372, 2000.
DOI : 10.1016/S0740-5472(99)00080-X

I. Salloum, J. Cornelius, D. Daley, L. Kirisci, J. Himmelhoch et al., Efficacy of Valproate Maintenance in Patients With Bipolar Disorder and Alcoholism, Archives of General Psychiatry, vol.62, issue.1, pp.37-45, 2005.
DOI : 10.1001/archpsyc.62.1.37

I. Salloum, J. Cornelius, and S. Chakravorthy, Utility of combined naltrexone valproate treatment in bipolar alcoholics: A randomized, open-label, pilot study Abstracts of Papers, 26th Annual Scientific Meeting of the Research Society on Alcoholism, pp.843-146, 2003.

I. Maremmani and M. Pacini, ABSTRACT, CNS Spectrums, vol.49, issue.02, pp.95-109, 2010.
DOI : 10.1016/0165-0327(79)90029-6

D. Johnson and N. Ait-daoud, Oral topiramate for treatment of alcohol dependence: a randomised controlled trial, The Lancet, vol.361, issue.9370, pp.1677-1685, 2003.
DOI : 10.1016/S0140-6736(03)13370-3

B. Johnson and N. Rosenthal, Topiramate for treating alcohol dependence: a randomized controlled trial, JAMA, vol.298, pp.1691-1692, 2007.

J. Merry and C. Reynolds, PROPHYLACTIC TREATMENT OF ALCOHOLISM BY LITHIUM CARBONATE A Controlled Study, The Lancet, vol.308, issue.7984, pp.481-482, 1976.
DOI : 10.1016/S0140-6736(76)90784-4

J. Fawcett and D. Clark, A Double-blind, Placebo-Controlled Trial of Lithium Carbonate Therapy for Alcoholism, Archives of General Psychiatry, vol.44, issue.3, pp.248-256, 1987.
DOI : 10.1001/archpsyc.1987.01800150060008

W. Dorus and D. Ostrow, Lithium Treatment of Depressed and Nondepressed Alcoholics, JAMA: The Journal of the American Medical Association, vol.262, issue.12, pp.1646-1652, 1989.
DOI : 10.1001/jama.1989.03430120100029

H. Kranzler, Evaluation and treatment of anxiety symptoms and disorders in alcoholics, J Clin Psychiatry, vol.57, pp.15-21, 1996.

C. J. Bukstein, O. Salloum, and I. , Alcohol and psychiatric comorbidity Recent Developments in Alcoholism, vol.16, pp.361-374, 2003.

H. R. Kranzler, J. A. Burleson, D. Boca, and F. K. , Buspirone treatment of anxious alcoholics . A placebo-controlled trial, Archives of General Psychiatry, pp.51-720, 1994.

S. Dawe and C. Gerada, Nicotine intake in smokers increases following a single dose of haloperidol, Psychopharmacology, vol.86, issue.1, pp.110-115, 1995.
DOI : 10.1001/archpsyc.1990.01810180067010

K. S. , H. D. , and J. S. , The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia, Hum. Psychopharmacol, vol.25, issue.2, pp.187-190, 2010.

P. Murthy and P. Chand, Treatment of dual diagnosis disorders, Current Opinion in Psychiatry, vol.25, issue.3, 2012.
DOI : 10.1097/YCO.0b013e328351a3e0

M. Machielsen and A. Beduin, Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine, Journal of Psychopharmacology, vol.42, issue.6, p.2012
DOI : 10.1016/j.pnpbp.2008.02.008

S. V. Zimmet, S. R. Burgess, and E. , Effects of Clozapine on Substance Use in Patients With Schizophrenia and Schizoaffective Disorder: A Retrospective Survey, Journal of Clinical Psychopharmacology, vol.20, issue.1, pp.94-98, 2000.
DOI : 10.1097/00004714-200002000-00016

H. Wijesundera, R. Hanwella, and V. De-silva, Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study, Annals of General Psychiatry, vol.13, issue.1, p.7, 2014.
DOI : 10.1017/S0033291713000548

B. J. Wu, C. H. , and L. S. , Do Atypical Antipsychotics Really Enhance Smoking Reduction More Than Typical Ones?, Journal of Clinical Psychopharmacology, vol.33, issue.3, pp.319-328, 2013.
DOI : 10.1097/JCP.0b013e31828b2575

R. Drake and H. Xie, The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia, Schizophrenia Bulletin, vol.26, issue.2, pp.441-449, 2000.
DOI : 10.1093/oxfordjournals.schbul.a033464

L. San and B. Arranz, Antipsychotic Drug Treatment of Schizophrenic Patients with Substance Abuse Disorders, European Addiction Research, vol.23, issue.4, pp.230-243, 2007.
DOI : 10.2165/00003495-200161010-00011

G. Martinotti and S. Andreoli, Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics, Human Psychopharmacology: Clinical and Experimental, vol.20, issue.1, pp.417-424, 2008.
DOI : 10.1159/000054017

M. Stedman, H. Pettinati, and E. Brown, A Double-Blind, Placebo-Controlled Study With Quetiapine as Adjunct Therapy With Lithium or Divalproex in Bipolar I Patients With Coexisting Alcohol Dependence, Alcoholism: Clinical and Experimental Research, vol.133, issue.3, pp.1822-1831, 2010.
DOI : 10.4088/JCP.v59n0405

E. Brown, M. Garza, and T. Carmody, A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Outpatients With Bipolar Disorder and Alcohol Use Disorders, The Journal of Clinical Psychiatry, vol.69, issue.5, pp.701-705, 2008.
DOI : 10.4088/JCP.v69n0502

E. Akerele and F. Levin, Comparison of Olanzapine to Risperidone in Substance-Abusing Individuals with Schizophrenia, American Journal on Addictions, vol.16, issue.4, pp.260-26817661193, 2007.
DOI : 10.1080/10550490701389658

S. Sevy, D. Robinson, and S. Sunday, Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes, Psychiatry Research, vol.188, issue.3, pp.310-314, 2011.
DOI : 10.1016/j.psychres.2011.05.001

M. Brunetti, D. Tizio, L. Dezi, and S. , Aripiprazole, alcohol and substance abuse: a review, Eur. Rev. Med. Pharmacol. Sci, vol.16, issue.10, pp.1346-1354, 2012.

T. Kishi, S. Sevy, and R. Chekuri, Antipsychotics for Primary Alcohol Dependence, The Journal of Clinical Psychiatry, vol.74, issue.07, pp.642-654, 2013.
DOI : 10.4088/JCP.12r08178

G. Van-de-glind and M. Konstenius, Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria, Drug and Alcohol Dependence, vol.134, pp.158-166, 2013.
DOI : 10.1016/j.drugalcdep.2013.09.026

F. R. Levin, S. M. Evans, and B. D. , Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo, Drug and Alcohol Dependence, vol.87, issue.1, pp.20-29, 2007.
DOI : 10.1016/j.drugalcdep.2006.07.004

M. Konstenius and N. Jayaram-lindström, Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial, Addiction, vol.20, issue.3, pp.440-449, 2014.
DOI : 10.1089/cap.2008.0128

H. and H. Autorité-de-santé, « Arrêt de la consommation de tabac : du dépistage individuel au maintient de l'abstinence en premier recours. Méthode Recommandations pour la pratique clinique, 2013.

M. Robert, . Anthenelli, L. Neal, and . Benowitz, Neuropsychiatric safety and effi cacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial, Lancet, vol.387, pp.2507-2527, 2016.

M. Beyens, C. Guy, G. Mounier, and S. Laporte, Serious Adverse Reactions of Bupropion for Smoking Cessation, Drug Safety, vol.24, issue.10, pp.1017-1026, 2001.
DOI : 10.1093/jat/16.5.343

K. Morley, A. Baillie, S. Leung, G. Addolorato, L. Leggio et al., Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety, Alcohol and Alcoholism, vol.34, issue.6, pp.654-60, 2014.
DOI : 10.1523/JNEUROSCI.4977-13.2014

A. Manteghi, P. Hebrani, M. Mortezania, M. Haghighi, and A. Javanbakht, Baclofen Add-on to Citalopram in Treatment of Posttraumatic Stress Disorder, Journal of Clinical Psychopharmacology, vol.34, issue.2, pp.240-243, 2014.
DOI : 10.1097/JCP.0000000000000089

R. Drake, L. Davis, M. Cates, M. Jewell, S. Ambrose et al., Baclofen Treatment for Chronic Posttraumatic Stress Disorder, Annals of Pharmacotherapy, vol.61, issue.9, pp.1177-81, 2003.
DOI : 10.1097/00004850-199903000-00001

E. Esel, K. Kose, Y. Hacimusalar, S. Ozsoy, M. Kula et al., The Effects of Electroconvulsive Therapy on GABAergic Function in Major Depressive Patients, The Journal of ECT, vol.24, issue.3, pp.224-232, 2008.
DOI : 10.1097/YCT.0b013e31815cbaa1

E. Ralevsky, O. Brien, E. Jane, and J. , Effects of Acamprosate on Cognition in a Treatment Study of Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence, The Journal of Nervous and Mental Disease, vol.199, issue.7, pp.499-505, 2011.
DOI : 10.1097/NMD.0b013e3182214297

. Maldonado, The endogenous opioid system and drug addiction, Ann Pharm Fr, p.2010

P. Tenore, CARF Review Data File Albert Einstein College of Medicine, Division of Substance Abuse, Division of Psychiatry, 2000.

S. Scarone, O. Gambini, G. Calabrese, P. Sacerdote, M. Bruni et al., Asymmetrical distribution of beta-endorphin in cerebral hemispheres of suicides: Preliminary data, Psychiatry Research, vol.32, issue.2, pp.159-66, 1990.
DOI : 10.1016/0165-1781(90)90082-G

A. Gabilondo, J. Meana, and J. García-sevilla, Increased density of ??-opioid receptors in the postmortem brain of suicide victims, Brain Research, vol.682, issue.1-2, pp.245-50, 1995.
DOI : 10.1016/0006-8993(95)00333-L

R. Gerner, D. Catlin, . Gorelick, K. Hui, C. Li et al., Intravenous infusion causes behavioral change in psychiatric inpatients Arch Gen Psychiatry, 1980.

, Ciofalo FR Methadone inhibitionof 3H-5-hydroxytryptamine uptake by synaptosomes, J Pharmacol Exp Ther, vol.189, 1974.

P. Gillman and . Monoamine-oxidase-inhibitors, Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity, British Journal of Anaesthesia, vol.95, issue.4, pp.434-475, 2005.
DOI : 10.1093/bja/aei210

URL : https://zenodo.org/record/844141/files/article.pdf

R. Callahan, J. Au, M. Paul, C. Liu, and C. Yost, Functional inhibition by methadone of Nmethyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects, Anesth Analg, vol.98, issue.3, pp.653-662, 2004.

A. Davis and C. Inturrisi, Methadone blocks morphine tolerance and N-methyl-Daspartate-induced hyperalgesia, J Pharmacol Exp Ther, vol.289, issue.2, pp.1048-53, 1999.

C. Zarate, J. Singh, P. Carlson, N. Brutsche, R. Ameli et al., A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression, Archives of General Psychiatry, vol.63, issue.8, pp.856-64, 2006.
DOI : 10.1001/archpsyc.63.8.856

R. Berman, A. Cappiello, A. Anand, D. Oren, G. Heninger et al., Antidepressant effects of ketamine in depressed patients, Biological Psychiatry, vol.47, issue.4, pp.351-355, 2000.
DOI : 10.1016/S0006-3223(99)00230-9

P. Gold, I. Extein, D. Pickar, R. Rebar, R. Ross et al., Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion, Am J Psychiatry, vol.137, issue.7, pp.862-865, 1980.

L. Judd, D. Parker, D. Janowsky, D. Segal, S. Risch et al., The effect of methadone on the behavioral and neuroendocrine responses of manic patients, Psychiatry Research, vol.7, issue.2, pp.163-70, 1982.
DOI : 10.1016/0165-1781(92)90089-L

I. Maremmani, O. Zolesi, M. Aglietti, and G. Marini, Methadone Dose and Retention During Treatment of Heroin Addicts with Axis I Psychiatric Comorbidity, Journal of Addictive Diseases, vol.25, issue.2, pp.29-41, 2000.
DOI : 10.1016/S0376-8716(97)00115-4

E. Peles, S. Schreiber, and M. Adelson, Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel, Drug and Alcohol Dependence, vol.82, issue.3, pp.2011-2018, 2006.
DOI : 10.1016/j.drugalcdep.2005.09.004

I. Maremmani, M. Pacini, S. Lubrano, G. Perugi, A. Tagliamonte et al., Long-Term Outcomes of Treatment-Resistant Heroin Addicts with and without DSM-IV Axis 1 Psychiatric Comorbidity (Dual Diagnosis), European Addiction Research, vol.14, issue.3, pp.134-176, 2008.
DOI : 10.1159/000130417

P. Pani, E. Trogu, P. Contu, A. Agus, and G. Gessa, Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program, Drug and Alcohol Dependence, vol.48, issue.2, pp.119-145, 1997.
DOI : 10.1016/S0376-8716(97)00115-4

C. Treece and B. Nicholson, DSM-III Personality Type and Dose Levels in Methadone Maintenance Patients, The Journal of Nervous and Mental Disease, vol.168, issue.10, pp.621-629, 1980.
DOI : 10.1097/00005053-198010000-00006

P. Pani, I. Maremmani, M. Pacini, F. Lamanna, A. Maremmani et al., Effect of Psychiatric Severity on the Outcome of Methadone Maintenance Treatment, European Addiction Research, vol.17, issue.2, pp.80-89, 2010.
DOI : 10.1159/000321465

P. Pani, I. Maremmani, R. Pirastu, A. Tagliamonte, and G. Gessa, Buprenorphine: a controlled clinical trial in the treatment of opioid dependence, Drug and Alcohol Dependence, vol.60, issue.1, pp.39-44, 2000.
DOI : 10.1016/S0376-8716(00)80006-X

A. Dean, J. Bell, M. Christie, and R. Mattick, Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence, European Psychiatry, vol.19, issue.8, pp.510-513, 2004.
DOI : 10.1016/j.eurpsy.2004.09.002

G. Gerra, F. Borella, A. Zaimovic, G. Moi, M. Bussandri et al., Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome . Drug Alcohol Depend, Jul, vol.1575, issue.1, pp.37-45, 2004.

A. Maremmani, L. Rovai, P. Pani, M. Pacini, F. Lamanna et al., Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?Ann Gen Psychiatry, p.17, 2011.

I. Maremmani, M. Pacini, and G. Perugi, Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patientsJ Subst Abuse Treat, pp.91-99, 2007.

P. P. Pani, R. Vacca, E. Trogu, L. Amato, and M. Davoli, Pharmacological treatment for depression during opioid agonist treatment for opioid dependence, Cochrane Database of Systematic Reviews, vol.16, issue.1
DOI : 10.1001/archpsyc.1967.01730230027003

H. Kleber, M. Weissman, B. Rounsaville, C. Wilber, and C. Prusoff, Imipramine as Treatment for Depression in Addicts, Archives of General Psychiatry, vol.40, issue.6, pp.649-53, 1983.
DOI : 10.1001/archpsyc.1983.04390010059007

G. Woody, O. Brien, C. Rickels, and K. , Depression and anxiety in heroin addicts: a placebocontrolled study of doxepin in combination with methadone, Am J Psychiatry, 1975.

E. Nunes, F. Quitkin, S. Donovan, D. Deliyannides, K. Ocepek-welikson et al., Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trialArch Gen Psychiatry, 1998.
DOI : 10.1001/archpsyc.55.2.153

URL : https://jamanetwork.com/journals/jamapsychiatry/articlepdf/190570/yoa6050.pdf

, Feb, vol.55, issue.2, pp.153-60

A. Dean, J. Bell, D. Mascord, G. Parker, and M. Christie, A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms, Journal of Affective Disorders, vol.72, issue.1, pp.85-90, 2002.
DOI : 10.1016/S0165-0327(01)00419-0

J. Titievsky, G. Seco, M. Barranco, and E. Kyle, Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study, J Clin Psychiatry, 1982.

I. Petrakis, K. Carrol, C. Nich, G. L. Kostent, and B. Rounsaville, Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug Alcohol Depend, pp.221-227, 1998.

K. Carpenter, A. Brooks, S. Vosburg, and E. Nunes, The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial, Drug and Alcohol Dependence, vol.74, issue.2, pp.123-157, 2004.
DOI : 10.1016/j.drugalcdep.2003.11.015

M. Fink, S. J. Itil, T. Freedman, and A. , Clinical antidepressant activity of cyclazocine-a narcotic antagonist, Clinical Pharmacology & Therapeutics, vol.11, issue.1, pp.41-49, 1970.
DOI : 10.1002/cpt197011141

A. Harcus, A. Ward, and D. Smith, Buprenorphine in postoperative pain: results in 7500 patients, Anaesthesia, vol.24, issue.4, pp.382-388, 1980.
DOI : 10.1007/BF03006232

G. Gerra, C. Leonardi, D. Amore, A. Strepparola, G. Fagetti et al., Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.30, issue.2, pp.265-72, 2005.
DOI : 10.1016/j.pnpbp.2005.10.007

H. Emrich, P. Vogt, and A. Herz, POSSIBLE ANTIDEPRESSIVE EFFECTS OF OPIOIDS: ACTION OF BUPRENORPHINE, Annals of the New York Academy of Sciences, vol.136, issue.1 Opioids in Me, pp.108-120, 1982.
DOI : 10.1176/ajp.136.12.1507

L. Mongan and E. Callaway, Buprenorphine responders.Biol Psychiatry, Dec, vol.1528, issue.12, pp.1078-80, 1990.
DOI : 10.1016/0006-3223(90)90619-d

T. Kosten, C. Morgan, and T. Koste, Depressive symptoms during buprenorphine treatment of opioid abusers, Journal of Substance Abuse Treatment, vol.7, issue.1, pp.51-55, 1990.
DOI : 10.1016/0740-5472(90)90035-O

J. Bodkin, G. Zornberg, S. Lukas, and J. Cole, Buprenorphine Treatment of Refractory Depression, Journal of Clinical Psychopharmacology, vol.15, issue.1, pp.49-57, 1995.
DOI : 10.1097/00004714-199502000-00008

J. Karp, M. Butters, A. Begley, M. Miller, E. Lenze et al., Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults, The Journal of Clinical Psychiatry, vol.75, issue.08, 2014.
DOI : 10.4088/JCP.13m08725

P. Nyhuis, M. Gastpar, and N. Sherbaum, Opiate Treatment in Depression Refractory to Antidepressants and Electroconvulsive Therapy, Journal of Clinical Psychopharmacology, vol.28, issue.5, pp.593-598, 2008.
DOI : 10.1097/JCP.0b013e31818638a4

G. Belenky and J. Holaday, The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate, Brain Research, vol.177, issue.2, pp.414-421, 1979.
DOI : 10.1016/0006-8993(79)90797-2

G. Marlatt, Cognitive factors in the relapse process Relapse prevention: maintenance stratégies in the treatment of addictive behaviors, 1985.

A. Beck, Cognitive therapy of substance abuse, 1993.

S. G. Hofmann and J. Smits, Cognitive-Behavioral Therapy for Adult Anxiety Disorders, The Journal of Clinical Psychiatry, vol.69, issue.4, pp.69-621, 2008.
DOI : 10.4088/JCP.v69n0415

. Van-emmerik-van-oortmerssen, Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial, BMC Psychiatry, vol.11, issue.1, p.132, 2013.
DOI : 10.1177/1087054707308502

H. Riper, Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis, Addiction, vol.195, issue.3, 2013.
DOI : 10.15288/jsad.2011.72.286

R. Brown, Cognitive???behavioral treatment for depression in alcoholism., Journal of Consulting and Clinical Psychology, vol.65, issue.5, pp.715-726, 1997.
DOI : 10.1037/0022-006X.65.5.715

L. Hides and K. Elkins, Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse ?, Med J Aust, vol.195, pp.31-37, 2011.

C. Barrowclough and G. Haddock, Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial, BMJ, vol.341, issue.nov24 3, p.6325, 2010.
DOI : 10.1136/bmj.c6325

URL : https://www.bmj.com/content/341/bmj.c6325.full.pdf

R. Weiss and L. Najavits, Relapse prevention group therapy for patients with coexisting substance use disorder and bipolar disorder, In : Problems of Drug Dependence, Proceedings of the 59 th Annual Scientific Meeting, pp.98-4305, 1997.

R. Nigam and R. Schottenfeld, Treatment of dual diagnosis patients: A relapse prevention group approach, Journal of Substance Abuse Treatment, vol.9, issue.4, pp.305-314, 1992.
DOI : 10.1016/0740-5472(92)90023-H

L. Roberts and A. Shaner, Overcoming addictions: skills training for people with schizophrenia, 1999.

A. Wilk and N. Jensen, Meta-analysis of Randomized Control Trials Addressing Brief Interventions in Heavy Alcohol Drinkers, Journal of General Internal Medicine, vol.12, issue.5, pp.274-283, 1997.
DOI : 10.1007/s11606-006-5063-z

K. Carrol and S. Ball, Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study, Drug and Alcohol Dependence, vol.81, issue.3, pp.301-312, 2006.
DOI : 10.1016/j.drugalcdep.2005.08.002

K. Carey and D. Purnine, Enhancing Readiness-to-Change Substance Abuse in Persons with Schizophrenia, Behavior Modification, vol.41, issue.3, pp.331-381, 2001.
DOI : 10.1093/schbul/23.2.229

URL : http://europepmc.org/articles/pmc2435265?pdf=render

A. Swanson and M. Pantalon, Motivational Interviewing and Treatment Adherence among Psychiatric and Dually Diagnosed Patients, The Journal of Nervous & Mental Disease, vol.187, issue.10, pp.630-635, 1999.
DOI : 10.1097/00005053-199910000-00007

P. Courty, Intervenir en toxicomanie, 2005.

A. Morel and R. Espaze, Troubles psychiatriques et comportements addictifs : Quelles collaborations entre centres spécialisés et secteurs psychiatriques, 2004.

A. Roche, E. Hotham, and R. Richmond, The general practitioner's role in AOD issues: overcoming individual, professional and systemic barriers, Drug and Alcohol Review, vol.21, issue.3, 2002.
DOI : 10.1080/0959523021000002679

M. Reynaud, A. Rigaud, S. Dally, J. Favre, and A. Morel, Addictions et comorbidités Comment travailler ensemble ? In: (4) AeA, editor. 2è assises nationales de la FFA, 2007.

M. Mcgovern, H. Xie, S. Segal, L. Siembab, and R. Drake, Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers, Journal of Substance Abuse Treatment, vol.31, issue.3, pp.267-75, 2006.
DOI : 10.1016/j.jsat.2006.05.003

C. Mercer-mc-fadden, K. Mueser, and R. Drake, The Community Support Program demonstrations of services for young adults with severe mental illness and substance use disorders, 1987???1991., Psychiatric Rehabilitation Journal, vol.20, issue.3, pp.13-24, 1997.
DOI : 10.1037/h0095368

R. Drake, S. Essock, A. Shaner, K. Carey, K. Minkoff et al., Implementing dual diagnosis services for clients with severe mental illness, Psychiatr Serv, 2001.

P. Flynn and B. Brown, Co-occurring disorders in substance abuse treatment: Issues and prospects, Journal of Substance Abuse Treatment, vol.34, issue.1, pp.36-47, 2007.
DOI : 10.1016/j.jsat.2006.11.013

J. Mestre-pintó and A. Domingo-salvany, Dual Diagnosis Screening Interview to Identify Psychiatric Comorbidity in Substance Users: Development and Validation of a Brief Instrument, European Addiction Research, vol.20, issue.1, pp.41-48, 2014.
DOI : 10.1159/000351519

W. Broadhead, A. Leon, M. Weissman, J. Barrett, R. Blacklow et al., Development and validation of the SDDS-PC screen for multiple mental disorders in primary care, Archives of Family Medicine, vol.4, issue.3, pp.211-219, 1995.
DOI : 10.1001/archfami.4.3.211

D. Sheehan, Y. Lecrubier, K. Sheehan, P. Amorim, J. Janavs et al., The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, vol.59, pp.22-33, 1998.

A. Lincoln, J. Liebschutz, M. Chernoff, D. Nguyen, and H. Amaro, Brief screening for cooccurring disorders among women entering substance abuse treatment, Substance Abuse Treatment, Prevention, and Policy, vol.1, issue.1, p.26, 2006.
DOI : 10.1186/1747-597X-1-26

R. Spitzer, K. Kroenke, and J. Williams, Validation and Utility of a Self-report Version of PRIME-MD<SUBTITLE>The PHQ Primary Care Study</SUBTITLE>, JAMA, vol.282, issue.18, pp.1737-1744, 1999.
DOI : 10.1001/jama.282.18.1737

A. Pierucci-lagha, J. Gelernter, R. Feinn, J. Cubells, D. Pearson et al., Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA), Drug and Alcohol Dependence, vol.80, issue.3, pp.303-312, 2005.
DOI : 10.1016/j.drugalcdep.2005.04.005

M. Torrens, D. Serrano, M. Astals, P. Dominguez, G. Martin-santos et al., Diagnosing Comorbid Psychiatric Disorders in Substance Abusers: Validity of the Spanish Versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV, American Journal of Psychiatry, vol.161, issue.7, pp.1231-1237, 2004.
DOI : 10.1176/appi.ajp.161.7.1231

D. Hasin, S. Samet, E. Nunes, J. Meydan, K. Matseoane et al., Diagnosis of Comorbid Psychiatric Disorders in Substance Users Assessed With the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV, American Journal of Psychiatry, vol.163, issue.4, pp.689-696, 2006.
DOI : 10.1176/ajp.2006.163.4.689